DongKook Pharmaceutical Statistics

Total Valuation

DongKook Pharmaceutical has a market cap or net worth of KRW 709.65 billion. The enterprise value is 775.65 billion.

Market Cap	709.65B
Enterprise Value	775.65B

Important Dates

The next estimated earnings date is Friday, March 7, 2025.

Earnings Date	Mar 7, 2025
Ex-Dividend Date	n/a

Share Statistics

DongKook Pharmaceutical has 43.97 million shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	n/a
Shares Outstanding	43.97M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	25.06%
Owned by Institutions (%)	19.23%
Float	23.94M

Valuation Ratios

The trailing PE ratio is 11.71 and the forward PE ratio is 10.75.

PE Ratio	11.71
Forward PE	10.75
PS Ratio	0.90
PB Ratio	1.23
P/TBV Ratio	1.25
P/FCF Ratio	27.18
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.05, with an EV/FCF ratio of 29.71.

EV / Earnings	12.58
EV / Sales	0.98
EV / EBITDA	7.05
EV / EBIT	9.29
EV / FCF	29.71

Financial Position

The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.11.

Current Ratio	2.13
Quick Ratio	1.32
Debt / Equity	0.11
Debt / EBITDA	0.69
Debt / FCF	2.88
Interest Coverage	16.69

Financial Efficiency

Return on equity (ROE) is 10.25% and return on invested capital (ROIC) is 7.43%.

Return on Equity (ROE)	10.25%
Return on Assets (ROA)	5.94%
Return on Capital (ROIC)	7.43%
Revenue Per Employee	697.71M
Profits Per Employee	54.50M
Employee Count	1,131
Asset Turnover	0.90
Inventory Turnover	2.30

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.36% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+5.36%
50-Day Moving Average	17,243.60
200-Day Moving Average	17,319.95
Relative Strength Index (RSI)	39.96
Average Volume (20 Days)	95,292

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DongKook Pharmaceutical had revenue of KRW 789.11 billion and earned 61.64 billion in profits. Earnings per share was 1,378.55.

Revenue	789.11B
Gross Profit	438.79B
Operating Income	82.91B
Pretax Income	82.77B
Net Income	61.64B
EBITDA	109.48B
EBIT	82.91B
Earnings Per Share (EPS)	1,378.55

Full Income Statement

Balance Sheet

The company has 89.61 billion in cash and 75.25 billion in debt, giving a net cash position of 14.35 billion or 326.46 per share.

Cash & Cash Equivalents	89.61B
Total Debt	75.25B
Net Cash	14.35B
Net Cash Per Share	326.46
Equity (Book Value)	657.59B
Book Value Per Share	13,128.33
Working Capital	255.82B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 57.08 billion and capital expenditures -30.97 billion, giving a free cash flow of 26.11 billion.

Operating Cash Flow	57.08B
Capital Expenditures	-30.97B
Free Cash Flow	26.11B
FCF Per Share	593.80

Full Cash Flow Statement

Margins

Gross margin is 55.61%, with operating and profit margins of 10.51% and 7.81%.

Gross Margin	55.61%
Operating Margin	10.51%
Pretax Margin	10.49%
Profit Margin	7.81%
EBITDA Margin	13.87%
EBIT Margin	10.51%
FCF Margin	3.31%

Dividends & Yields

This stock pays an annual dividend of 180.00, which amounts to a dividend yield of 1.12%.

Dividend Per Share	180.00
Dividend Yield	1.12%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	13.48%
Buyback Yield	-0.01%
Shareholder Yield	1.10%
Earnings Yield	8.54%
FCF Yield	3.68%

Dividend Details

Stock Splits

The last stock split was on August 24, 2020. It was a forward split with a ratio of 5.

Last Split Date	Aug 24, 2020
Split Type	Forward
Split Ratio	5

Scores

DongKook Pharmaceutical has an Altman Z-Score of 4.03.

Altman Z-Score	4.03
Piotroski F-Score	n/a